Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States.

Early vaccination against influenza viruses is a cost-effective solution to prevent contagion and reduce influenza-related morbidity and mortality. In the face of pandemic viruses, such as the A(H1N1), adequate rates of vaccine uptake play a critical role in containing the spread and effects of the disease. In order to understand the reasons underlying the relatively low 2009-2010 A(H1N1) vaccination rates, we conducted an online survey of 1569 respondents drawn from a nationally representative sample of United States (U.S.) adults age 18, and older. Because prior research suggests that vaccination rates are especially low among some U.S. population subgroups, we oversampled participants from minority ethnic/racial groups and those living under the Federal Poverty Level. Our results show that A(H1N1) vaccine uptake is associated with sociodemographic factors, A(H1N1)-related beliefs and seasonal vaccination. That is, A(H1N1) vaccination is strongly associated with age, urbanicity, perceiving the A(H1N1) vaccine as safe and seasonal flu vaccine uptake. Perceptions of safety and season flu vaccination show the strongest associations with A(H1N1) uptake. The reasons people gave to decline vaccination varied by respondents' sociodemographic group. For example, Black participants were the most likely ethnic/racial group to reported having tried to get the vaccine but found it unavailable. Together, these findings suggest some clear pointers towards strategic public health communication efforts calling for communication campaigns towards audiences segmented by social class, race/ethnicity and beliefs, often what advertisers call "psychodemographics".

[1]  Jean-Paul Moatti,et al.  Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance? , 2010, PloS one.

[2]  L. Egede,et al.  Racial/ethnic differences in adult vaccination among individuals with diabetes. , 2003, American journal of public health.

[3]  N. Lurie,et al.  Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults. , 2009, Vaccine.

[4]  T. Davis,et al.  Childhood immunization refusal: provider and parent perceptions. , 2004, Family medicine.

[5]  Chris T Bauch,et al.  Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. , 2010, Vaccine.

[6]  Truls Østbye,et al.  Racial differences in influenza vaccination among older americans 1996–2000: longitudinal analysis of the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) survey , 2003, BMC public health.

[7]  P. Streefland,et al.  Patterns of vaccination acceptance. , 1999, Social science & medicine.

[8]  M. Setbon,et al.  Factors in vaccination intention against the pandemic influenza A/H1N1 , 2010, European journal of public health.

[9]  J. Horney,et al.  Intent to Receive Pandemic Influenza A (H1N1) Vaccine, Compliance with Social Distancing and Sources of Information in NC, 2009 , 2010, PloS one.

[10]  S. Galea,et al.  Determinants of influenza vaccination in hard-to-reach urban populations. , 2006, Preventive medicine.

[11]  R. Blendon,et al.  The public's response to the 2009 H1N1 influenza pandemic. , 2010, The New England journal of medicine.

[12]  L. Balluz,et al.  Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009. , 2010, MMWR. Morbidity and mortality weekly report.